AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Solvent viscosity and interrelated effects on electrochemiluminescence intensity of tris(2,2 '-bipyridyl)ruthenium(II)
Authors: Scott, AM Pyati, R
Citation: Am. Scott et R. Pyati, Solvent viscosity and interrelated effects on electrochemiluminescence intensity of tris(2,2 '-bipyridyl)ruthenium(II), J PHYS CH B, 105(37), 2001, pp. 9011-9015
Current status of positron emission tomography in oncology
Authors: Scott, AM
Citation: Am. Scott, Current status of positron emission tomography in oncology, INTERN M J, 31(1), 2001, pp. 27-36
Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model
Authors: Tahtis, K Lee, FT Smyth, FE Power, BE Renner, C Brechbiel, MW Old, LJ Hudson, PJ Scott, AM
Citation: K. Tahtis et al., Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model, CLIN CANC R, 7(4), 2001, pp. 1061-1072
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial
Authors: Scott, AM Lee, FT Hopkins, W Cebon, JS Wheatley, JM Liu, ZQ Smyth, FE Murone, C Sturrock, S MacGregor, D Hanai, N Inoue, K Yamasaki, M Brechbiel, MW Davis, ID Murphy, R Hannah, A Lim-Joon, M Chan, T Chong, G Ritter, G Hoffman, EW Burgess, AW Old, LJ
Citation: Am. Scott et al., Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial, J CL ONCOL, 19(19), 2001, pp. 3976-3987
Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector
Authors: Power, BE Caine, JM Burns, JE Shapira, DR Hattarki, MK Tahtis, K Lee, FT Smyth, FE Scott, AM Kortt, AA Hudson, PJ
Citation: Be. Power et al., Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector, CANCER IMMU, 50(5), 2001, pp. 241-250
Targeting properties of an anti-CD16/anti-CD30 bispecific: antibody in an in vivo system
Authors: Renner, C Stehle, I Lee, FT Hall, C Catimel, B Nice, EC Mountain, A Rigopoulos, A Brechbiel, MW Pfreundschuh, M Scott, AM
Citation: C. Renner et al., Targeting properties of an anti-CD16/anti-CD30 bispecific: antibody in an in vivo system, CANCER IMMU, 50(2), 2001, pp. 102-108
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients
Authors: Tanswell, P Garin-Chesa, P Rettig, WJ Welt, S Divgi, CR Casper, ES Finn, RD Larson, SM Old, LJ Scott, AM
Citation: P. Tanswell et al., Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients, BR J CL PH, 51(2), 2001, pp. 177-180
Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft
Authors: Barendswaard, EC Humm, JL O'Donoghue, JA Sgouros, G Finn, RD Scott, AM Larson, SM Welt, S
Citation: Ec. Barendswaard et al., Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft, J NUCL MED, 42(8), 2001, pp. 1251-1256
Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody
Authors: Lee, FT Hall, C Rigopoulos, A Zweit, J Pathmaraj, K O'Keefe, GJ Smyth, FE Welt, S Old, LJ Scott, AM
Citation: Ft. Lee et al., Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody, J NUCL MED, 42(5), 2001, pp. 764-769
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
Authors: Ramdave, S Thomas, GW Berlangieri, SU Bolton, DM Davis, I Tochon-Danguy, H MacGregor, D Scott, AM
Citation: S. Ramdave et al., Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma, J UROL, 166(3), 2001, pp. 825-830
Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo
Authors: Gallicchio, MA Kneen, M Hall, C Scott, AM Bach, LA
Citation: Ma. Gallicchio et al., Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo, INT J CANC, 94(5), 2001, pp. 645-651
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001)
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor (vol 61, pg 5349, 2001), CANCER RES, 61(20), 2001, pp. 7703-7703
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor
Authors: Mishima, K Johns, TG Luwor, RB Scott, AM Stockert, E Jungbluth, AA Ji, XD Suvarna, P Voland, JR Old, LJ Huang, HJS Cavenee, WK
Citation: K. Mishima et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, CANCER RES, 61(14), 2001, pp. 5349-5354
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR
Authors: Luwor, RB Johns, TG Murone, C Huang, HJS Cavenee, WK Ritter, G Old, LJ Burgess, AW Scott, AM
Citation: Rb. Luwor et al., Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR, CANCER RES, 61(14), 2001, pp. 5355-5361
Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts
Authors: Lee, FT Rigopoulos, A Hall, C Clarke, K Cody, SH Smyth, FE Liu, ZQ Brechbiel, MW Hanai, N Nice, EC Catimel, B Burgess, AW Welt, S Ritter, G Old, LJ Scott, AM
Citation: Ft. Lee et al., Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts, CANCER RES, 61(11), 2001, pp. 4474-4482
Efficient high-gain laser amplification from a low-gain amplifier by use of self-imaging multipass geometry
Authors: Scott, AM Cook, G Davies, APG
Citation: Am. Scott et al., Efficient high-gain laser amplification from a low-gain amplifier by use of self-imaging multipass geometry, APPL OPTICS, 40(15), 2001, pp. 2461-2467
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy
Authors: Clarke, K Lee, FT Brechbiel, MW Smyth, FE Old, LJ Scott, AM
Citation: K. Clarke et al., Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy, CLIN CANC R, 6(9), 2000, pp. 3621-3628
The fate of hypoxic tissue on F-18-fluoromisonidazole positron emission tomography after ischemic stroke
Authors: Read, SJ Hirano, T Abbott, DF Markus, R Sachinidis, JI Tochon-Danguy, HJ Chan, JG Egan, GF Scott, AM Bladin, CF McKay, WJ Donnan, GA
Citation: Sj. Read et al., The fate of hypoxic tissue on F-18-fluoromisonidazole positron emission tomography after ischemic stroke, ANN NEUROL, 48(2), 2000, pp. 228-235
Valley of the shadow: Two communities in the American Civil War; The eve of war
Authors: Scott, AM
Citation: Am. Scott, Valley of the shadow: Two communities in the American Civil War; The eve of war, LIBRARY J, 125(20), 2000, pp. 203-203
Use of (F-18)-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy
Authors: Hannah, A Feigen, M Quong, G Akhurst, T Berlangieri, SU Zimet, A Zalcberg, J McKay, WJ Scott, AM
Citation: A. Hannah et al., Use of (F-18)-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy, OTO H N SUR, 122(2), 2000, pp. 304-306
The build-up of stimulated Brillouin scattering excited by pulsed pump radiation in a long optical fibre
Authors: Kovalev, VI Harrison, RG Scott, AM
Citation: Vi. Kovalev et al., The build-up of stimulated Brillouin scattering excited by pulsed pump radiation in a long optical fibre, OPT COMMUN, 185(1-3), 2000, pp. 185-189
Metabolic staging of lung cancer.
Authors: Berlangieri, SU Scott, AM
Citation: Su. Berlangieri et Am. Scott, Metabolic staging of lung cancer., N ENG J MED, 343(4), 2000, pp. 290-292
Psychological and sex features of delayed gut transit in functional gastrointestinal disorders
Authors: Bennett, EJ Evans, P Scott, AM Badcock, CA Shuter, B Hoschl, R Tennant, CC Kellow, JE
Citation: Ej. Bennett et al., Psychological and sex features of delayed gut transit in functional gastrointestinal disorders, GUT, 46(1), 2000, pp. 83-87
Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3
Authors: Achen, MG Roufail, S Domagala, T Catimel, B Nice, EC Geleick, DM Murphy, R Scott, AM Caesar, C Makinen, T Alitalo, K Stacker, SA
Citation: Mg. Achen et al., Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3, EUR J BIOCH, 267(9), 2000, pp. 2505-2515
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice
Authors: Clarke, K Lee, FT Brechbiel, MW Smyth, FE Old, LJ Scott, AM
Citation: K. Clarke et al., In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice, CANCER RES, 60(17), 2000, pp. 4804-4811
Risultati: 1-25 | 26-31